1Samuel NM, Srijayanth P, Dharmarajan S, et al. Acceptance of HIV-1 education & voluntary counselling/testing by & seroprevalence of HIV-1 among, pregnant women in rural south India[J]. India J Med Res,2007,125(1) :49 -64.
2Guyatt GH, Oxman AD, Vist GE, et al. Rating quality ofevidence and strength of recommendations: GRADE: anemerging consensus on rating quality of evidence and strength ofrecommendations[J]. BMJ,2008,336(7650):924.
3ChuCM, Liaw YF. Genotype C hepatitis B virus infection isassociated with a higher risk of reactivation of hepatitis B andprogression to cirrhosis than genotype B: a longitudinal study ofhepatitis B antigen-positive patients with normal aminotransferaselevels at baseline[J]. J Hepatol,2005,43(3):411-417.
4Okada K, Kamiyama I,Inomata M, et al. E antigen and anti-ein the serum of asymptomatic carrier mothers as indicators ofpositive and negative transmission of hepatitis B virus to theirinfants[J]. N Engl J Med,1976,294(14):746-749.
5ZouH, Chen Y,Duan Z, et al. Protective effect of hepatitis Bvaccine combined with two-dose hepatitis B immunoglobulinon infants bron to HBsAg-positive motherfj]. PlusOne,2011,6(10):267-268.
6Shaheen AA, Myers RP. The outcomes of pregnancy in patientswith cirrhosis: a population-based study [J]. Liver Int,2010,30(2):275-283.
7Shi Z, Yang Y, Ma L, et al. Lamivudine in late pregnancyto interrupt in utero transmission of hepatitis B virus:a systematic review and meta-analysis[J]. ObstetGynecol,2010,116(1):147-159.
8Liu M, Cai H,Yi W. Safety of telbivudine treatmentfor chronic hepatitis B for the entire pregnancy. J ViralHepat,2013(20 Suppl 1):65-70.
9Chou YC, Yu MW, Wu CF, et al. Temporal reUtionshipbetween hepatitis B virus enhancer II/basal core promotersequence variation and risk of hepatocelluar carcinoma[J].Gut,2008,57(1):91-97.
